Reports from the EAU “Update on Prostate Cancer” meeting in Vienna

The European Association of Urology (EAU) “Update on Prostate Cancer” meeting was held in Vienna, Austria, on Friday and Saturday, and Dr. Zachary Klaassen was again busy providing summary reports on presentations for UroToday. … READ MORE …

Shift-work, night-work, and risk for prostate cancer

Yet another study (this one from Germany) has shown a strong association between shift-work and night-work and risk for diagnosis with prostate cancer. … READ MORE …

What’s luminal water imaging, and do we need to care?

Two recent papers by Sabouri et al. have suggested that a new MRI techique known as “luminal water imaging” may be able to improve the ability of MR scans to identify and grade prostate cancer prior to biopsy. … READ MORE …

More on statins and the management of prostate cancer

A recent data analysis for the Danish national health registry systems has once again provided confirmation of a link between statin use and risk of prostate cancer-specific mortality. … READ MORE …

IL-35 levels in the diagnosis and prognosis of prostate cancer

A new paper by a group of Chinese researchers has suggested that levels of a biochemical called interleukin-35 (IL-35) in blood plasma may offer evidence of the presence of prostate cancer and do so significantly better than PSA levels (particularly for men with PSA levels of between 4 and 10 ng/ml). … READ MORE …

Does Test X change what physicians actually do and say to their patients?

One of the key ways in which we can (and do) assess the “value” of new types of medical test is by the degree to which they actually change the ways physicians act on the data and make decisions and/or recommendations about patient management. … READ MORE …

It’s not “as big a deal as you might think”

What isn’t as big a deal as we might think? According to The New York Times this morning, the US Preventive Services Task Force’s new recommendations about prostate cancer screening. … READ MORE …